Becker's Healthcare September 5, 2024
Interest in Cigna’s GLP-1 management program is “through the roof,” CEO David Cordani told investors.
“Clients are looking at — how do you balance expanding access, but in a more sustainable way?” Mr. Cordani said at an investor conference on Sept. 5.
In March, Cigna launched EncircleRx, a program to help employers manage the costs of the drugs. The program grew to more than 2 million enrollees in its first six months.
Mr. Cordani said that around 50% of the large employers served by Evernorth, Cigna’s health services business, cover GLP-1 drugs for weight loss.
A smaller percentage of Cigna Healthcare’s clients, the company’s insurance benefits business, have opted to cover the cost of the drugs for...
Today's Sponsors
Today's Sponsor